Chordate Medical AB
Niklas Lindecrantz is a seasoned financial professional with extensive experience serving as a part-time CFO for multiple organizations, including ETNetwork AB / Kwick, Chordate Medical AB, Scint-X AB, Key2Compliance®, Beleco, BlackWing Sweden, and Instabridge AB. Lindecrantz has also been the owner of Lzinvest, focusing on interim management and investments since 2014. Additionally, Lindecrantz held the role of Part-Time Business Controller for Energiföretagen Sverige and served on the board of DYNAMO Digital Ventures from 2014 to 2018. Lindecrantz obtained a Bachelor of Science in Finance from Stockholm University and completed education at Hersby Gymnasium.
This person is not in any teams
Chordate Medical AB
Chordate Medical is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Ozilia™ Migraine. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm.